期刊文献+

肿瘤干细胞与肝癌关系的相关研究进展 被引量:1

Research Progress in Tumor Stem Cell and Liver Cancer
暂未订购
导出
摘要 肿瘤干细胞学说对肿瘤起源的传统理论提出了质疑,并已获得较多的证据支持,正逐渐被人们所接受。肿瘤干细胞学说为恶性肿瘤的基础研究及临床治疗指明了一个新的方向。原发性肝癌在我国的发病率较高,且呈上升趋势。近年来研究发现,肝癌细胞中存在着一群具有特异性的肿瘤细胞,称为肝癌干细胞,其发现促使人们对原有的关于肝癌形成、发展及治疗理论进行重新审视。该文试从干细胞的概念、肿瘤干细胞学说的形成及其生物学特性、肝癌干细胞的来源及表面标志物的研究进展等方面作一综述。 Tumor stem cell theory has challenged the traditional theory ot tumor origin and has got quite a few evidences, which is being accepted gradually by people. Tumor stem cell theory has showed a new direction for both basic research and elinieal treatment of malignat tumors. In China, the incidence of primary liver cancer is relatively high, and shows an increasing trend. Recent research shows that there is a speeial group of tumor cells in the liver cancer cells ,which are called liver cancer stem ceils. This new finding ha., changed people′s traditional ideas about the etiology, development and treatment of liver cancer. Here is to make a review of the concept of stem cells,the formation of tumor stern cell theory,the biological characteristics of tumor stem cells .the origin of liver cancer stem cells and tumor surface markers.
出处 《医学综述》 2014年第24期4472-4474,共3页 Medical Recapitulate
关键词 肿瘤干细胞 生物学特性 肝癌干细胞 Neoplastic stem cell Biological characteristics Liver cancer stem cells
  • 相关文献

参考文献46

  • 1Khaitov RM,Petrov RV,Gambarov SS,et al.Stem cells and T and B lymphocytes during tumor growth[J].Cell Immunol,1976,22(1):1-10.
  • 2Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and cancer stem cells[J].Nature,2001,414(6859):105-111.
  • 3王小利,马博,贾军,袁艳华,严颖,邸立军,宋国红,余靖,任军.rAAV/CEA转染树突状细胞诱导特异性CTL杀伤MCF-7细胞系CD44~+CD24^(-/low)乳腺癌干细胞[J].北京大学学报(医学版),2011,43(2):173-178. 被引量:17
  • 4朱峰,王敏,秦仁义,申铭,王欣,田锐,张志发,石程剑.人胰腺癌干细胞对吉西他滨的敏感性及其分子机制研究[J].华中科技大学学报(医学版),2010,39(3):281-287. 被引量:4
  • 5仇波,张东勇,陶钧,吴安华,王运杰.一种简化改良的脑胶质瘤干细胞培养方法[J].中国神经肿瘤杂志,2011,9(1):7-11. 被引量:3
  • 6Trerotola M,Rathore S,Goel HL,et al.CD133,Trop-2 and alpha2-beta1 integrin surface receptors as markers of putative human prostate cancer stem cells[J].Am J Transl Res,2010,2(2):135-144.
  • 7Clarke MF,Dick JE,Dirks PB,et al.Cancer stem cells--perspectives on current status and future directions:AACR Workshop on cancer stem cells[J].Cancer Res,2006,66(19):9339-9344.
  • 8Reachy PA,Karhadkar SS,Berman DM.Tissue repairand stein cell renewal in carcinogenesie[J].Nature,2004,432(7015):324-330.
  • 9Todaro M,Francipane MG,Medema JP,et al.Colon cancer stem cells:promise of targeted the rapy[J].Gastroenterology,2010,138(6):2151-2162.
  • 10Shackleton M.Normal stem cells and cancer stem cells:similar and different[J].Semin Cancer Biol,2010,20(2):85-92.

二级参考文献165

共引文献55

同被引文献33

  • 1蔡永娥,乔建锦,孙晓茹,崔英.我国原发性肝癌研究进展[J].现代肿瘤医学,2008,16(1):141-143. 被引量:32
  • 2Wicker CA,Sahu RP,Kulkarni-Datar K,et al.BITC sensi-tizes pancreatic adenocarcinomas to TRAIL-induced apoptosis[J].Cancer Growth Metastasis,2010,2009(2):45-55.
  • 3Tiwary R,Yu W,Li J,et al.Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis[J].PLo S One,2010,5(7):e11865.
  • 4Peter A Holoch,Thomas S Griffith.TNF-related apoptosisinducing ligand(TRAIL):a new path to anti-cancer therapies[J].Eur J Pharmacol,2009,625(1-3):63-72.
  • 5Sung B,Ravindran J,Prasad S,et al.Gossypol induces death receptor-5 through activation of ROS-ERK-chop pathway and sensitizes colon cancer cells to trail[J].J Biol Chem,2010,285(46):35418-35427.
  • 6Edagawa M,Kawauchi J,Hirata M,et al.Role of activating transcription factor 3(ATF3)in endoplasmic reticulum(ER)stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor(TNF)-related apoptosisinducing ligand(TRAIL)-mediated apoptosis through upregulation of death receptor 5(DR5)by zerumbone and celecoxib[J].J Biol Chem,2014,289(31):21544-21561.
  • 7J Lemke,S von Karstedt,J Zinngrebe,et al.Getting TRAIL back on track for cancer therapy[J].Cell Death Differ,2014,21(9):1350-1364.
  • 8Ehrhardt H,Wachter F,Grunert M,et al.Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis[J].Cell Death Dis,2013,4(6):e661.
  • 9Zhang SJ,Li GQ,Zhao YF,et al.Smac mimetic SM-164potentiates APO2L/TRAIL-and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cells[J].PLo S One,2012,7(12):e51461.
  • 10Shankar S,Srivastava RK.Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation:mechanisms and clinical implications[J].Drug Resist Updat,2004,7(2):139-156.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部